Singular Genomics Systems, Inc.
OMIC

NASDAQ > Medical - Instruments & Supplies
DCF:$0.90  |   P/E: -
$1.52(-10.13%)
Change
Rating:
Price: $15 USD
Market Cap: $33.64M

...Loading OMIC Peers...





Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

    255 Employees

    CEO : Mr. Andrew Spaventa

    Address : 10931 North Torrey Pines Road, La Jolla,CA, US, - 92037,

Key ExcutivesDesignation
Mr. Eric StierSenior Vice President, General Counsel & Secretary
Mr. Jorge Velarde Jr., MBAChief Business Officer
Dr. Jyotsna Ghai Ph.D.Chief Operating Officer
Mr. Dalen MeeterChief Financial Officer
Dr. David L. Barker Ph.D.Founder, Member of Scientific Advisory Board & Independent Director
Dr. Eli N. Glezer Ph.D.Founder, Chief Scientific Officer & Chair of Scientific Advisory Board
Mr. Jeff BullardHead of Sales
Mr. Andrew SpaventaFounder, Chief Executive Officer, President & Chairperson of the Board
Mr. Vincent BrancaccioHead of Human Resources